EDAP TMS S.A. (EDAP)

Market Cap	81.26M
Revenue (ttm)	70.72M
Net Income (ttm)	-24.67M
Shares Out	37.10M
EPS (ttm)	-0.66
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,596
Open	2.190
Previous Close	2.190
Day's Range	2.180 - 2.280
52-Week Range	2.140 - 8.500
Beta	0.34
Analysts	Strong Buy
Price Target	19.00 (+767.58%)
Earnings Date	Nov 7, 2024

About EDAP

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urolog...

• Industry: Medical Distribution
• Sector: Healthcare
• IPO Date: Jul 31, 1997
• Employees: 307
• Stock Exchange: NASDAQ
• Ticker Symbol: EDAP
• Website: https://www.edap-tms.com

Financial Performance

In 2023, EDAP TMS's revenue was 60.42 million, an increase of 9.64% compared to the previous year's 55.11 million. Losses were -21.18 million, 622.1% more than in 2022.

Financial numbers in EUR

Analyst Forecast

According to one analyst, the rating for EDAP stock is "Strong Buy" and the 12-month stock price forecast is $19.0.

Price Target

$19.0

(767.58% upside)

Analyst Consensus: Strong Buy